Beena Goldenberg

How Germany's Cannabis Market Is Dominating Europe And Unlocking New Profit Opportunities

Organigram Reports 25% YoY Increase In Q3 Net Revenue, Significant Improvement In Adjusted EBITDA

Organigram Supports Cannabis In Germany With $15M Initial Investment In This Berlin Marijuana Co.

Organigram Reports 25% YoY Increase In Q3 Net Revenue, Significant Improvement In Adjusted EBITDA

Organigram Supports Cannabis In Germany With $15M Initial Investment In This Berlin Marijuana Co.

Organigram Reports 262% Higher Quarterly Net Loss YoY, Makes Progress In International Markets

No Cannabis Tax Relief In Canada, Tilray CEO Says This 'Hinders Our Ability To Compete With The Illicit Market'

Organigram Reports 262% Higher Quarterly Net Loss YoY, Makes Progress In International Markets

No Cannabis Tax Relief In Canada, Tilray CEO Says This 'Hinders Our Ability To Compete With The Illicit Market'

Organigram Reports 16% YoY Revenue Drop But Kicks Off Year 'With A Bang,' Says CEO On Hundreds Of Millions In Tobacco Giant BAT Investment

Organic Growth And Innovation Drive YoY Increase In Cannabis Producer Organigram's Q4 Revenue And Adjusted EBITDA

Beena Goldenberg Recent News

$69B Tobacco Giant Supports Cannabis With $91M Investment In Toronto Weed Producer

Canadian cannabis company Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced on Monday a CA$124.6 million ($91.2 million) follow-on strategic equity investment from BT DE Investments Inc., a wholly-owned subsidiary of tobacco giant

Organigram Makes Strides In Global Cannabis Industry With New Supply Partnership

Organigram Holdings Inc.

Organigram To Enter German Cannabis Market Via Sanity Group

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) has entered into a supply agreement for dried flower with the medical division of German cannabis company Sanity Group.

Organigram Shares Trading Lower On Q2 FY23 Revenue Growth Of 24% YoY

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) net revenue in Q2 fiscal 2023 increased 24% to CA$39.5 million ($29.3 million), from CA$31.8 million in Q2 fiscal 2022.

Organigram Accelerates Focus On Vapes With Strategic Investment In Greentank

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) has entered into a product purchase agreement with Green Tank Technologies Corp. and a subscription agreement with Greentank’s parent company, Weekend Holdings Corp.

Organigram Shares Jump On Q1 2023 Record Harvest And Adjusted Gross Margin

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI), released its results for the first quarter ended November 30, 2022., revealing net revenue of CA$43.3 million, ($32.3 million) a 43% increase compared to CA$30.4 million in the Q1 fiscal 2022.

Why You Should Consider Investing In This Marijuana Stock: One Of Canada's Best Operators, Says Analyst

OrganiGram Holdings Inc. (NASDAQ: OGI) recently reported that its net revenue in the 2022 fiscal year increased 84% to CS$145.8 million ($107.9 million) from CA$79.2 million in the previous

Organigram Q4 Revenue Grows 83% YoY, Provides Outlook

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) released its results for the fourth quarter and year ended August 31, 2022, revealing net revenue in FY 2022 increased 84% to $145.8 million from $79.2 million in the previous year primarily due to an increase in recreational

Organigram To Supply Israeli Cannabis Co. InterCure With Up To 20,000 Kg Of Dried Flower

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) and Canndoc Ltd., a subsidiary of InterCure Ltd.

Organigram Revenue Grows 88% YoY, Provides Outlook

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) released results for the third quarter ended May 31, 2022, revealing net revenue increased 88% to $38.1 million, from $20.3 million in Q3 Fiscal 2021.

Cannabis & Burdensome Excise Tax: Canadian Operators Urge Changes As Pot Prices Drop

Canadian cannabis operators are urging lawmakers to amend current excise taxes as weed prices drop. With the decline of marijuana prices, the flat-fee tax structure is disadvantageous, to say the least, reported The Globe and

Organigram Q2 Fiscal 2022 Revenue Grows 117% YoY Primaraly Because Of This

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI), the parent company of Organigram Inc., released its results for the second quarter ended February 28, 2022.

Why Organigram Shares Are Trading Higher Today? Posts Record High Net Revenue In Q2, Still Among Top Canadian LPs

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of the cannabis company Organigram Inc, announced its results for the second quarter ended February 28, 2022.

Organigram Joins The Pledge 1% Movement To Help Local Volunteer Programs

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) launched its social impact strategy ‘Organigram Operating for Good’ with the purpose of ‘Building healthy communities where we live and work.’ As part of this strategy the company has committed to giving back by

Organigram Gets Additional CA$6.3M Investment From BAT, Which Raises Its Stake In The Company To 19.5%

BAT Exercises Top-Up Rights to Invest $6.3 Million Resulting in an Increase in Equity Position from 18.8% to 19.5%

Organigram Reports Highest Quarterly Net Revenue Ever In Q1, Remains Among Top Canadian Cannabis LPs

Cannabis company Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced its results for the first quarter ended November 30, 2021.

Benzinga Interview: Organigram CEO Beena Goldenberg Discusses Company Performance And Canadian Cannabis Market

OrganiGram Holdings Inc (NASDAQ: OGI) (TSE: OGI) CEO Beena Goldenberg recently spoke with Benzinga to discuss the company's ongoing growth and Q2 success.

Organigram Invests Additional $2.5M In CBD Biotech Co Hyasynth, Wraps Up $10M Debenture Purchase Deal

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) has acquired an additional $2.5 million of secured convertible debentures in Hyasynth Biologicals Inc.

Organigram Q4 Revenue Grows 22% YoY To $24.9M, Remains #4 Cannabis LP In Canada

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) released its results Tuesday for the fourth fiscal quarter ended August 31, 2021, reporting net revenue of $24.9 million, up by 22% from $20.04 million in the same quarter of fiscal 2020.

Organigram Launches New CBD Wellness Brand: Vegan-Friendly & Sugar-Free Soft Chews

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI), the parent company of Canadian cannabis producer Organigram Inc. is launching a new wellness brand - Monjour, which is offering high-quality, CBD-forward produ

Cannabis Mergers: Canopy Growth Issues 9 Million Shares To Complete Acquisition Of Supreme Cannabis Co.

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) has merged with The Supreme Cannabis Company, Inc.

Supreme Cannabis Q3 Revenue Plunges Ahead Of Merger With Canopy Growth

The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) reported Thursday having earned $16.8 million in gross revenue in the third quarter of 2021, representing a sequential decrease of 22.5%.

Supreme Cannabis Names Beena Goldenberg President And CEO

The Supreme Cannabis Company Inc (TSX:FIRE) (OTC: SPRWF) confirmed Monday it has hired Beena Goldenberg as its president and CEO, succeeding Colin Moore.